By IDSE News Staff
The FDA cleared the cobas Malaria test for use on the cobas 6800/8800 systems (cobas Malaria, Roche Molecular Systems), the first FDA-licensed test for screening blood donors for Plasmodium DNA and RNA in whole blood samples to reduce the risk for transfusion-transmitted malaria.
Cobas Malaria is a qualitative in vitro nucleic acid screening test for the direct detection of Plasmodium (P. falciparum, P. knowlesi, P. malariae, P. ovale and P. vivax) DNA and RNA in whole